Memo Therapeutics Funding: $69M Raised, Series C (2023)

Memo Therapeutics funding overview

Memo Therapeutics is based in Schlieren / Zurich, Switzerland. Memo Therapeutics has raised $69M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in November 2023. The round record for Memo Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Pureos Bioventures, Swisscanto Invest, Vesalius Biocapital, Adjuvant Capital, Verve Ventures, Schroders Capital and 8 others. 14 distinct backers are named across the disclosed rounds.

Memo Therapeutics at a glance

Total raised: $69M
Latest round: Series C
Latest round date: November 2023
Headquarters: Schlieren / Zurich, Switzerland
Notable investors: Pureos Bioventures, Swisscanto Invest, Vesalius Biocapital, Adjuvant Capital, Verve Ventures, Schroders Capital, GF Group, Fresenius Medical Care Ventures

Frequently asked about Memo Therapeutics funding

How much has Memo Therapeutics raised?: Memo Therapeutics has raised $69M in total disclosed funding across the rounds on record.
Who has invested in Memo Therapeutics?: Pureos Bioventures, Swisscanto Invest, Vesalius Biocapital, Adjuvant Capital, Verve Ventures, Schroders Capital are named among the investors backing Memo Therapeutics.
What was the latest Memo Therapeutics funding round?: The most recent disclosed round is a Series C, announced in November 2023.
Where is Memo Therapeutics based?: Memo Therapeutics is based in Schlieren / Zurich, Switzerland.
When did Memo Therapeutics last raise?: The last disclosed Memo Therapeutics round closed in November 2023 at Series C.

Totals shown for Memo Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Schlieren / Zurich and the investors behind them below.

Memo Therapeutics Funding: $69M Raised, Series C (2023)

Memo Therapeutics funding overview

Memo Therapeutics at a glance

Frequently asked about Memo Therapeutics funding

Companies related to Memo Therapeutics (40)

Browse related funding lists (7)